Clinical Consequences Of Tablet Crushing

Figure shows what the release of a normal twice daily dose of a tablet should look like with respect to its serum concentration (blood level) over time once it has reached steady state. The two lines provided show the concentration at which the drug is more likely to work and the concentration at which it is more likely to cause side effects. The range of concentration where the drug is more likely to work and less likely to cause side effects is caused the 'therapeutic window'. Many drugs have a large therapeutic window and therefore occasional missed or extra doses don't really affect the drug's efficacy. For some drugs however the therapeutic window is relatively small e.g. digoxin, carbamazepine, theophylline, phenytoin and in such circumstances slight changes in dose can change whether the drug is effective or whether it is likely to cause side effects.

Although drugs like metformin and nifedipine have wide therapeutic windows patients can suffer from 'peak effects' and this is where they get side effects when the concentration is at its highest and for this reason they are made into slow release formulations to reduce the height of the peak and therefore reduce side effects.

Crushing tablets with small therapeutic effects or those with peak effects (Figure 2) increases the chances of side effects and times when the drug is less likely to work.

Drugs are frequently formulated into modified release tablets or capsules so that the patient doesn't have to remember to take them so often and also to reduce peak effects (Figure 3). These formulations are excellent and are commonly used for the control of pain e.g. MST. Because each tablet or capsule holds a relatively large dose of the drug crushing the formulation significantly increases the maximum serum levels and reduced the minimum serum levels (Figure 4) and consequently can cause side effects and periods where the drug is not working at all.